SG Americas Securities
ELV icon

SG Americas Securities’s Elevance Health ELV Stock Holding History

SG Americas Securities’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$233M Buy
796,553
+561,300
+239% +$184M 0.25% 59
2025
Q4 		$82.5M Buy
235,253
+231,541
+6,238% +$78.2M 0.11% 148
2025
Q3 		$1.2M Sell
3,712
-105,403
-97% -$32.8M ﹤0.01% 1291
2025
Q2 		$42.4M Buy
109,115
+100,206
+1,125% +$40.3M 0.18% 86
2025
Q1 		$3.88M Sell
8,909
-269
-3% -$108K 0.01% 554
2024
Q4 		$3.39M Sell
9,178
-8,764
-49% -$3.67M 0.01% 434
2024
Q3 		$9.33M Sell
17,942
-11,759
-40% -$6.28M 0.03% 286
2024
Q2 		$16.1M Sell
29,701
-2,883
-9% -$1.52M 0.09% 225
2024
Q1 		$16.9M Buy
32,584
+23,649
+265% +$11.8M 0.08% 248
2023
Q4 		$4.21M Buy
8,935
+2,220
+33% +$1.03M 0.04% 391
2023
Q3 		$2.92M Sell
6,715
-5,225
-44% -$2.37M 0.03% 524
2023
Q2 		$5.3M Buy
11,940
+6,349
+114% +$2.93M 0.04% 345
2023
Q1 		$2.57M Buy
5,591
+4,631
+482% +$2.2M 0.03% 544
2022
Q4 		$492K Sell
960
-161,162
-99% -$81.8M 0.01% 1544
2022
Q3 		$73.6M Buy
162,122
+70,849
+78% +$33.9M 0.91% 17
2022
Q2 		$44M Buy
91,273
+83,036
+1,008% +$41.1M 0.47% 29
2022
Q1 		$4.05M Sell
8,237
-8,471
-51% -$3.87M 0.03% 515
2021
Q4 		$7.75M Buy
16,708
+10,806
+183% +$4.55M 0.04% 340
2021
Q3 		$2.2M Sell
5,902
-3,483
-37% -$1.32M 0.01% 1185
2021
Q2 		$3.58M Sell
9,385
-14,688
-61% -$5.61M 0.02% 769
2021
Q1 		$8.64M Sell
24,073
-60,440
-72% -$19.4M 0.05% 327
2020
Q4 		$27.1M Buy
84,513
+77,922
+1,182% +$23.9M 0.14% 111
2020
Q3 		$1.77M Sell
6,591
-11,653
-64% -$3.14M 0.01% 814
2020
Q2 		$4.8M Buy
18,244
+1,685
+10% +$450K 0.04% 367
2020
Q1 		$3.76M Buy
16,559
+13,271
+404% +$3.62M 0.04% 495
2019
Q4 		$993K Sell
3,288
-44,403
-93% -$12.2M 0.01% 1267
2019
Q3 		$11.5M Buy
47,691
+21,261
+80% +$5.83M 0.09% 217
2019
Q2 		$7.46M Sell
26,430
-89,053
-77% -$24.3M 0.05% 377
2019
Q1 		$33.1M Buy
115,483
+92,234
+397% +$26.7M 0.31% 60
2018
Q4 		$6.11M Sell
23,249
-33,963
-59% -$9.34M 0.05% 323
2018
Q3 		$15.7M Buy
57,212
+49,780
+670% +$12.9M 0.12% 175
2018
Q2 		$1.77M Sell
7,432
-15,345
-67% -$3.55M 0.02% 1006
2018
Q1 		$5M Sell
22,777
-19,759
-46% -$4.64M 0.04% 423
2017
Q4 		$9.57M Buy
42,536
+32,687
+332% +$6.96M 0.09% 193
2017
Q3 		$1.87M Sell
9,849
-129,847
-93% -$24.7M 0.02% 840
2017
Q2 		$26.3M Sell
139,696
-35,576
-20% -$6.39M 0.24% 84
2017
Q1 		$29M Buy
175,272
+128,175
+272% +$20.4M 0.26% 80
2016
Q4 		$6.77M Sell
47,097
-44,119
-48% -$5.91M 0.06% 351
2016
Q3 		$11.4M Buy
91,216
+81,424
+832% +$10.5M 0.12% 159
2016
Q2 		$1.29M Sell
9,792
-55,517
-85% -$7.6M 0.01% 1137
2016
Q1 		$9.08M Buy
65,309
+49,905
+324% +$6.67M 0.07% 227
2015
Q4 		$2.15M Sell
15,404
-18,891
-55% -$2.6M 0.02% 672
2015
Q3 		$4.8M Buy
34,295
+16,559
+93% +$2.49M 0.03% 385
2015
Q2 		$2.91M Sell
17,736
-35,120
-66% -$5.61M 0.02% 564
2015
Q1 		$8.16M Sell
52,856
-39,192
-43% -$5.58M 0.05% 269
2014
Q4 		$11.6M Sell
92,048
-5,986
-6% -$740K 0.06% 343
2014
Q3 		$11.7M Buy
98,034
+37,862
+63% +$4.34M 0.07% 287
2014
Q2 		$6.47M Sell
60,172
-100,726
-63% -$10.4M 0.04% 489
2014
Q1 		$16M Sell
160,898
-694,442
-81% -$62.8M 0.07% 318
2013
Q4 		$79M Buy
855,340
+548,464
+179% +$48.7M 0.33% 63
2013
Q3 		$25.7M Buy
306,876
+60,128
+24% +$5.15M 0.11% 188
2013
Q2 		$20.2M Buy
+246,748
New +$18.5M 0.1% 200

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

SG Americas Securities's ELV Position: Q1 2026 in Review

SG Americas Securities increased its Elevance Health (ELV) stake by 239% in Q1 2026, buying an estimated $184M and bringing the position to 796,553 shares worth $233M. The position accounts for 0.25% of the portfolio, ranked #59.

SG Americas Securities first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • SG Americas Securities held 796,553 shares of Elevance Health worth $233M as of Q1 2026.
  • SG Americas Securities bought 561,300 Elevance Health shares in Q1 2026, an estimated $184M.
  • Elevance Health made up 0.25% of SG Americas Securities's portfolio in Q1 2026, its #59 holding.
  • SG Americas Securities first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.